ketohexokinase inhibitors (Johnson & Johnson)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameketohexokinase inhibitors (Johnson & Johnson)
Drug Alias NameJNJ-28165722JNJ-42740815JNJ-42065426JNJ-42740828JNJ-42152981
ClassificationSmall molecules
Mechanisms of ActionKetohexokinase inhibitors
TargetsKetohexokinase
Therapy Area/IndicationsObesityHypertriglyceridemiaDiabetes Mellitus +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsObesityHypertriglyceridemiaDiabetes Mellitus +[4

Other Information

ATC CodeN/A
Related LinksN/A